Hypertrophic Scarring: Current Knowledge of Predisposing Factors, Cellular and Molecular Mechanisms

Layla Nabai1, Amir Pourghadiri1, Aziz Ghahary1

  • 1BC Professional Firefighters' Burn & Wound Healing Research Laboratory, Department of Surgery, Division of Plastic Surgery, University of British Columbia, Vancouver, British Columbia, Canada.

Insights

Hypertrophic scarring (HSc) remains a significant challenge despite medical advances. Understanding the cellular and molecular factors driving HSc is key to developing effective treatments.

Area of Science:

  • Dermatology
  • Wound Healing
  • Fibroproliferative Disorders

Background:

  • Hypertrophic scarring (HSc) presents a persistent clinical challenge, impacting millions physically, psychologically, and economically.
  • Current preventive and therapeutic strategies for HSc are limited, despite progress in surgical techniques and wound care.
  • A deeper understanding of HSc pathophysiology is essential for advancing clinical interventions.

Purpose of the Study:

  • To review current knowledge on predisposing factors for hypertrophic scarring.
  • To elucidate the cellular and molecular mechanisms underlying hypertrophic scar formation.
  • To provide a foundation for developing novel preventive and therapeutic strategies for HSc.

Main Methods:

  • Literature review of predisposing factors in hypertrophic scarring.
  • Comprehensive analysis of cellular mechanisms in HSc development.
  • Detailed examination of molecular pathways involved in fibroproliferative disorders.

Main Results:

  • Significant advancements have been made in understanding the cellular and molecular underpinnings of HSc.
  • Key predisposing factors contributing to HSc have been identified.
  • The review synthesizes current knowledge on the pathophysiology of HSc.

Conclusions:

  • Continued research into HSc pathophysiology is critical for improving patient outcomes.
  • Elucidating molecular mechanisms offers potential targets for HSc treatment.
  • A comprehensive understanding is vital for developing effective HSc prevention and management strategies.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
307
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
603
Overview of Regeneration and Repair01:19

Overview of Regeneration and Repair

Regeneration and repair processes are critical in healing damages caused by injury, disease, and aging. In regeneration, the damaged tissue is entirely replaced with new growth that restores the original architecture and function. In contrast, tissue repair usually results in a fixed tissue architecture involving scar formation. Scars generally do not reestablish tissue function and may also exhibit structural abnormalities at the injury site.
Regeneration
All animals have varying degrees of...
4.9K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.1K
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.7K